|MDACC Study No:||2011-1036 (clinicaltrials.gov NCT No: NCT01512589)|
|Title:||Phase III Randomized Trial of Proton Beam Therapy versus Intensity-Modulated Radiation Therapy for the treatment of esophageal cancer|
|Principal Investigator:||Steven H. Lin|
|Treatment Agent:||5-Fluorouracil; Docetaxel; Intensity Modulated Radiotherapy; Proton Therapy|
|Study Description:||The goal of this clinical research study is to learn how safe and effective |
proton-beam therapy (PBT) may be in comparison to intensity modulated radiation
therapy (IMRT) in combination with chemotherapy in patients with esophageal
PBT and IMRT are both forms of radiation therapy that are designed to treat a
specific area of the body while affecting as little of the surrounding normal
tissue as possible. PBT is a newer technology that is designed to further
reduce the amount of radiation that affects the surrounding normal tissue.
However, this is still being studied.